NCT02642640View on ClinicalTrials.gov

Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

March 24, 2022

Study Completion Date

March 24, 2022

Conditions
GlucoseCircadian RhythmMelatoninGenes
Interventions
DIETARY_SUPPLEMENT

melatonin

5 mg of melatonin per os.

DRUG

placebo

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT02642640 - Interaction of Melatonin and MTNR1B Genotype on Glucose Control - Study 1 | Biotech Hunter | Biotech Hunter